In 2024, dermatologicals is set to post double-digit growth in retail current value terms in Brazil. Although all categories are expected to see growth, hair loss treatments is anticipated to see the strongest increase from a low base, with medicated shampoos also set to see an above-average increase from a higher base. A common concern amongst Brazilian men in particular is hair loss, which can be addressed with these products. Hair loss can be linked to a decrease in confidence and self-esteem

Dermatologicals in India is set to see mid-single-digit growth in retail current value terms in 2024, primarily driven by above-average growth for topical germicidals/antiseptics and topical antifungals. Trusted household brands such as Boroline, which has long been a staple in Indian homes for wound healing and skin protection, have contributed significantly to the category’s resilience. Similarly, antifungal products such as Itch Guard, Ring Guard, and Candid are widely used for treating commo

The dermatologicals market in Singapore experienced a mixed performance in 2024, with growth primarily driven by medicated shampoos. During the initial stages of the pandemic, social restrictions led to more time spent at home, which caused many consumers to pay less attention to personal appearance. This shift in focus contributed to a current value decline for medicated shampoos between 2020 and 2022, as consumers prioritised essential spending during the uncertain times. However, as social re

Dermatologicals continued to record strong single-digit retail value growth in Austria in 2024. The end of social distancing after COVID-19 continued to benefit sales of dermatologicals like medicated shampoos, hair loss treatment and topical germicidals. Topical germicidals saw a boost in sales due to a rise in injuries following increased physical activity, including outdoor sports. In addition, many Austrians are increasingly interested in investing in products to help minimise and counter th

Dermatologicals in Germany continues to experience healthy current value growth in 2024. Notable developments are the rising demand for treatments addressing hair loss, cold sores, and haemorrhoids. Growing demand for appearance-related products is significantly boosting demand for hair loss treatments and medicated shampoos (under beauty and personal care).

The dermatologicals market in Indonesia is set for continued growth in current value terms in 2024, with nappy (diaper) rash treatments leading the way. Millions of babies in Indonesia suffer from nappy rash, boosting demand for these remedies. According to the Indonesian Paediatrician Association (IDAI), babies' skin has a higher pH level than that of adults, making it more prone to dryness. This promotes the growth of harmful bacteria, increasing the likelihood of nappy rash. As a result, napp

In 2024, Romania’s dermatologicals market is expected to see slower growth compared to other OTC categories, with some segments still recovering from pandemic-related shifts in consumer behaviour. Acne remains the top concern, fuelling demand for targeted treatments. Additionally, the hectic pace of modern life and stress have exacerbated skin issues such as breakouts and irritation, further contributing to the demand for dermatological solutions. However, inflation and economic challenges have

Trends in dermatologicals in Cameroon are being driven by the rising prevalence of skin-related diseases in 2024. This is connected to local issues around access to water, sanitation and hygiene (WASH). Indeed, a lack of portable water which has resulted to Cameroonians using water sources from wells, streams, and boreholes, thus increasing susceptibility to skin infections such as ringworm, eczema, rashes, and other fungal infections on the skin.

Demand for dermatologicals in North Macedonia has remained reasonably stable in 2024, with all categories expanding in volume terms. Sales continue to be buoyed by the fact that various acute and chronic skin-related problems are becoming more prevalent among the population due to a combination of genetic, demographic, lifestyle and environmental factors. At the same time, rising health awareness and the evolution of the self-medication trend mean consumers are increasingly well-informed about t

Dermatologicals in Poland are expected to register minimal constant value growth in 2024, with volume sales also falling across many product areas. Topical antifungals, as well as nappy (diaper) rash treatments, continue to account for most value sales, but cold sore treatments, as well as hair loss treatments are expected to register the highest volume growth in 2024. Hair loss treatments is an emerging sector, with plenty of room for further growth. Increasingly men are becoming more conscious

Price increases were the main driver of current value sales in dermatologicals, reaching double-digit growth in 2024. In February, the Ministry of Health intervened to increase prices by up to 16% in several subcategories, such as vaginal antifungals, topical allergy remedies, antihistamines, and haemorrhoid treatments. Other categories, such as medicated shampoo and hair loss treatments are increasing prices due to inflation and rising import costs.

Retail sales of dermatologicals show positive growth in 2024; however, the category in Uzbekistan lacks development, largely due to the limited emphasis that locals place on dermatological practices. As a consequence, there is a tendency for Uzbeks to economise when buying dermatological products, with many only applying products for vital issues and often postponing treatments. This can also be linked to low levels of disposable income and the volatile nature of the local currency, with fluctua

Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary facilities. In particular, skin conditions such as ringworm are common. Moreover, eczema and other skin disorders are growing, partly due to worsening pollution. Dermocosmetics such as acne treatments are also seeing growth, driven by increased access to so

Dermatologicals has posted healthy growth in current value terms in 2024 although much of this derives from rising unit prices. Inflation has been driven upwards by the impact of Russia’s ongoing war in Ukraine while foreign currency exchange rates have come under pressure, which has taken its toll on dermatologicals which relies on a number of imported products. This has placed a cap on volume growth as dermatologicals are often not seen as the first priority in the treatment of minor skin comp

The market for dermatologicals in Switzerland is anticipated to maintain its positive trajectory in 2024. Self-medication remains prevalent within this category, driving overall growth. Factors such as busy lifestyles, embarrassment surrounding certain skin conditions, and a desire to avoid costly doctor visits are motivating Swiss consumers to seek OTC dermatological solutions, particularly in topical and vaginal antifungals.

Value sales of dermatologicals in South Africa continue to rise in 2024, with demand increasing across the category. Strong contributors to value sales include topical germicidals/antiseptics (Zam-Buk, Dettol), topical allergy remedies/antihistamines (Phenergan), topical antifungals (Lamisil), and antiparasitics/lice (head and body) treatments (Para, Controlice).

Dermatologicals has been a particularly dynamic category over the review period and continues to record moderate volume growth in 2024 due to solid demand and strong value growth as a result of rising prices due to inflation. Consumer demand for dermatologicals in Slovenia is largely driven by ongoing innovation and new product development by renowned manufacturers. The growth of e-commerce is also supporting the expansion of the market throughout the country. In addition, consumers are progress

Dermatologicals in Serbia recorded strong double-digit current value growth in 2024 stimulated by unit price increases. Consumer awareness regarding the various treatments available for dermatological problems has also improved in recent years, encouraging sales. Moreover, Serbians are getting better access to medical checkups and therefore advice from a doctor which is supporting sales of dermatologicals.

The market for dermatological products in Taiwan is poised for positive, albeit modest, growth in current value terms in 2024, with the significant prevalence of skin diseases in the country underscoring this trend. Taiwan's subtropical climate, characterised by high humidity and warm temperatures, fosters conditions that can lead to fungal infections, such as tinea and athlete's foot. Additionally, the spicy foods commonly found in Taiwanese cuisine can irritate the skin, potentially exacerbati

Dermatologicals in Sweden experienced healthy growth in current value terms over 2024. One notable development was the buoyant demand for antiparasitics/lice treatments, continuing the trend of the previous year. With children spending more time socialising outside the home, they were more exposed to environments which could lead to lice infestations. Similarly, hair loss treatments continued to see growth in 2024. With life back to normal after the pandemic the increase in socialising and on-si

Dermatologicals in Kenya is experiencing a shift towards natural and herbal products, driven by growing consumer awareness of the potential side effects of chemical-based treatments. Consumers are increasingly seeking gentler alternatives with natural ingredients, such as African black soap and shea butter, which are perceived as safer and more beneficial for long-term skin health. Brands like Earthy Skin Essentials are gaining traction by highlighting their use of indigenous raw materials, whil

Dermatologicals continue to benefit from the increasing number of Turkish consumers investing in their appearance, a trend which increased when COVID-19 restrictions eased. Investing in appearance is further driven by the professional working environment, social arena and growing use of social media. Specifically, beauty and personal appearance boost the demand for dermatologicals to improve skin health and/or support a more youthful look, such as more robust, fuller hair.

Due to climate change, Uruguay is experiencing warmer weather and an extended rainfall season during 2024. These weather conditions have resulted in a strong outbreak of the mosquito-spread virus, dengue fever, which will give extra strength to the category. As a result, antipruritics is becoming the best performing dermatological in 2024, which is led by Urufarma with Prurisedan, followed by Spefar with Cortifar. The category remains very active in terms of product innovation. For example, Spef

Dermatologicals is posting robustly positive current value growth in Lithuania in 2024, that is more impressive than that of some other consumer health categories. Still, as is the case across much of the industry, growth is largely generated by rising prices rather than higher volume sales.